Company intelligence / Profile preview

Health Care Originals

Rochester, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Health Care Originals' Nightingale and ADAMM platforms are clinically validated, showing improved management of asthma and COPD with outcomes such as fewer attacks, better sleep, and high patient engagement. The solution is used for real-time monitoring, personalized reporting, and earlier identification of exacerbation risks, and is reimbursable by insurance following the Dawn Health acquisition.

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceDigital therapeuticAI-enabled monitoring platform
Industry: Physiological Monitoring

Partnerships

University of Rochester (technology origin/patent)Venture investors (Safar Partners, Chloe Capital)Various health plans and payors (through recent expansion into insurance reimbursement for virtual respiratory care)

Beyond the preview

Go deeper on Health Care Originals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Health Care Originals.

Explore the full profile